APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cold, Cough and Sore Throat Remedies

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Cold, Cough and Sore Throat Remedies Market Outlook and Growth Opportunities 2026

19 December 2025191 pages

Choose your research edition.

Industry ResearchCold, Cough and Sore Throat Remedies Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Cold, Cough and Sore Throat Remedies Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal Cold, Cough and Sore Throat Remedies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cold, Cough and Sore Throat Remedies Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Cold, Cough and Sore Throat Remedies Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Cold, Cough and Sore Throat Remedies market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Cold, Cough and Sore Throat Remedies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cold, Cough and Sore Throat Remedies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cold, Cough and Sore Throat Remedies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Cold, Cough and Sore Throat Remedies market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Cold, Cough and Sore Throat Remedies market include Prestige Brands, Reckitt Benckiser, Sun Pharmaceutical Industries, AstraZeneca, Bayer, GlaxoSmithKline, Pfizer, Novartis and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Cold, Cough and Sore Throat Remedies market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cold, Cough and Sore Throat Remedies and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cold, Cough and Sore Throat Remedies revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Cold, Cough and Sore Throat Remedies market.

Cold, Cough and Sore Throat Remedies Segment by Company

Prestige Brands

Reckitt Benckiser

Sun Pharmaceutical Industries

AstraZeneca

Bayer

GlaxoSmithKline

Pfizer

Novartis

Johnson & Johnson

Cold, Cough and Sore Throat Remedies Segment by Type

Decongestants

Antibiotics

Antihistamines

Expectorants

Bronchodilators

Others

Cold, Cough and Sore Throat Remedies Segment by Application

Hospital Pharmacies

Retail Pharmacies

Drug Stores

Cold, Cough and Sore Throat Remedies Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Cold, Cough and Sore Throat Remedies status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Cold, Cough and Sore Throat Remedies key companies, revenue, market share, and recent developments.

3. To split the Cold, Cough and Sore Throat Remedies breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Cold, Cough and Sore Throat Remedies market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Cold, Cough and Sore Throat Remedies significant trends, drivers, influence factors in global and regions.

6. To analyze Cold, Cough and Sore Throat Remedies competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cold, Cough and Sore Throat Remedies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cold, Cough and Sore Throat Remedies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cold, Cough and Sore Throat Remedies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Cold, Cough and Sore Throat Remedies industry.

Chapter 3: Detailed analysis of Cold, Cough and Sore Throat Remedies company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Cold, Cough and Sore Throat Remedies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Cold, Cough and Sore Throat Remedies in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Cold, Cough and Sore Throat Remedies Industry Trends Table 2. Cold, Cough and Sore Throat Remedies Industry Drivers Table 3. Cold, Cough and Sore Throat Remedies Industry Opportunities and Challenges Table 4. Cold, Cough and Sore Throat Remedies Industry Restraints Table 5. Global Cold, Cough and Sore Throat Remedies Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Cold, Cough and Sore Throat Remedies Revenue Share by Company (2021-2026) Table 7. Global Cold, Cough and Sore Throat Remedies Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Cold, Cough and Sore Throat Remedies Key Company Manufacturing Base & Headquarters Table 9. Global Cold, Cough and Sore Throat Remedies Company, Product Type & Application Table 10. Global Cold, Cough and Sore Throat Remedies Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Cold, Cough and Sore Throat Remedies by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Decongestants Table 15. Significant Companies of Antibiotics Table 16. Significant Companies of Antihistamines Table 17. Significant Companies of Expectorants Table 18. Significant Companies of Bronchodilators Table 19. Significant Companies of Others Table 20. Global Cold, Cough and Sore Throat Remedies Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Cold, Cough and Sore Throat Remedies Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Cold, Cough and Sore Throat Remedies Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Cold, Cough and Sore Throat Remedies Sales Value Share by Type (2021-2026) Table 24. Global Cold, Cough and Sore Throat Remedies Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Hospital Pharmacies Table 26. Significant Companies of Retail Pharmacies Table 27. Significant Companies of Drug Stores Table 28. Global Cold, Cough and Sore Throat Remedies Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Cold, Cough and Sore Throat Remedies Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Cold, Cough and Sore Throat Remedies Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Cold, Cough and Sore Throat Remedies Sales Value Share by Application (2021-2026) Table 32. Global Cold, Cough and Sore Throat Remedies Sales Value Share by Application (2027-2032) Table 33. Global Cold, Cough and Sore Throat Remedies Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Cold, Cough and Sore Throat Remedies Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Cold, Cough and Sore Throat Remedies Sales Value Share by Region (2021-2026) Table 36. Global Cold, Cough and Sore Throat Remedies Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Cold, Cough and Sore Throat Remedies Sales Value Share by Region (2027-2032) Table 38. Global Cold, Cough and Sore Throat Remedies Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Cold, Cough and Sore Throat Remedies Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Cold, Cough and Sore Throat Remedies Sales Value Market Share by Country (2021-2026) Table 41. Global Cold, Cough and Sore Throat Remedies Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Cold, Cough and Sore Throat Remedies Sales Value Market Share by Country (2027-2032) Table 43. Prestige Brands Company Information Table 44. Prestige Brands Business Overview Table 45. Prestige Brands Cold, Cough and Sore Throat Remedies Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Prestige Brands Cold, Cough and Sore Throat Remedies Product Portfolio Table 47. Prestige Brands Recent Development Table 48. Reckitt Benckiser Company Information Table 49. Reckitt Benckiser Business Overview Table 50. Reckitt Benckiser Cold, Cough and Sore Throat Remedies Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Reckitt Benckiser Cold, Cough and Sore Throat Remedies Product Portfolio Table 52. Reckitt Benckiser Recent Development Table 53. Sun Pharmaceutical Industries Company Information Table 54. Sun Pharmaceutical Industries Business Overview Table 55. Sun Pharmaceutical Industries Cold, Cough and Sore Throat Remedies Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Sun Pharmaceutical Industries Cold, Cough and Sore Throat Remedies Product Portfolio Table 57. Sun Pharmaceutical Industries Recent Development Table 58. AstraZeneca Company Information Table 59. AstraZeneca Business Overview Table 60. AstraZeneca Cold, Cough and Sore Throat Remedies Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. AstraZeneca Cold, Cough and Sore Throat Remedies Product Portfolio Table 62. AstraZeneca Recent Development Table 63. Bayer Company Information Table 64. Bayer Business Overview Table 65. Bayer Cold, Cough and Sore Throat Remedies Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Bayer Cold, Cough and Sore Throat Remedies Product Portfolio Table 67. Bayer Recent Development Table 68. GlaxoSmithKline Company Information Table 69. GlaxoSmithKline Business Overview Table 70. GlaxoSmithKline Cold, Cough and Sore Throat Remedies Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. GlaxoSmithKline Cold, Cough and Sore Throat Remedies Product Portfolio Table 72. GlaxoSmithKline Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer Cold, Cough and Sore Throat Remedies Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Pfizer Cold, Cough and Sore Throat Remedies Product Portfolio Table 77. Pfizer Recent Development Table 78. Novartis Company Information Table 79. Novartis Business Overview Table 80. Novartis Cold, Cough and Sore Throat Remedies Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Novartis Cold, Cough and Sore Throat Remedies Product Portfolio Table 82. Novartis Recent Development Table 83. Johnson & Johnson Company Information Table 84. Johnson & Johnson Business Overview Table 85. Johnson & Johnson Cold, Cough and Sore Throat Remedies Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Johnson & Johnson Cold, Cough and Sore Throat Remedies Product Portfolio Table 87. Johnson & Johnson Recent Development Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. Cold, Cough and Sore Throat Remedies Product Image Figure 2. Global Cold, Cough and Sore Throat Remedies Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cold, Cough and Sore Throat Remedies Market Size (2021-2032) & (US$ Million) Figure 4. Global Cold, Cough and Sore Throat Remedies Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Decongestants Image Figure 8. Antibiotics Image Figure 9. Antihistamines Image Figure 10. Expectorants Image Figure 11. Bronchodilators Image Figure 12. Others Image Figure 13. Global Cold, Cough and Sore Throat Remedies Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Cold, Cough and Sore Throat Remedies Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Cold, Cough and Sore Throat Remedies Sales Value Share by Type (2021-2032) Figure 16. Hospital Pharmacies Image Figure 17. Retail Pharmacies Image Figure 18. Drug Stores Image Figure 19. Global Cold, Cough and Sore Throat Remedies Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Cold, Cough and Sore Throat Remedies Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Cold, Cough and Sore Throat Remedies Sales Value Share by Application (2021-2032) Figure 22. Global Cold, Cough and Sore Throat Remedies Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Cold, Cough and Sore Throat Remedies Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Cold, Cough and Sore Throat Remedies Sales Value (2021-2032) & (US$ Million) Figure 25. North America Cold, Cough and Sore Throat Remedies Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Cold, Cough and Sore Throat Remedies Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Cold, Cough and Sore Throat Remedies Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Cold, Cough and Sore Throat Remedies Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Cold, Cough and Sore Throat Remedies Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Cold, Cough and Sore Throat Remedies Sales Value (2021-2032) & (US$ Million) Figure 31. South America Cold, Cough and Sore Throat Remedies Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Cold, Cough and Sore Throat Remedies Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Cold, Cough and Sore Throat Remedies Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Decongestants
  • Antibiotics
  • Antihistamines
  • Expectorants
  • Bronchodilators
  • Others
Applications
  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
Companies covered
  • Prestige Brands
  • Reckitt Benckiser
  • Sun Pharmaceutical Industries
  • AstraZeneca
  • Bayer
  • GlaxoSmithKline
  • Pfizer
  • Novartis
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cold, Cough and Sore Throat Remedies Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cold, Cough and Sore Throat Remedies Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Cold, Cough and Sore Throat Remedies Market Dynamics
  1. 2.1 Cold, Cough and Sore Throat Remedies Industry Trends
  2. 2.2 Cold, Cough and Sore Throat Remedies Industry Drivers
  3. 2.3 Cold, Cough and Sore Throat Remedies Industry Opportunities and Challenges
  4. 2.4 Cold, Cough and Sore Throat Remedies Industry Restraints
3 Cold, Cough and Sore Throat Remedies Market by Company
  1. 3.1 Global Cold, Cough and Sore Throat Remedies Company Revenue Ranking in 2025
  2. 3.2 Global Cold, Cough and Sore Throat Remedies Revenue by Company (2021-2026)
  3. 3.3 Global Cold, Cough and Sore Throat Remedies Company Ranking (2024-2026)
  4. 3.4 Global Cold, Cough and Sore Throat Remedies Company Manufacturing Base and Headquarters
  5. 3.5 Global Cold, Cough and Sore Throat Remedies Company Product Type and Application
  6. 3.6 Global Cold, Cough and Sore Throat Remedies Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Cold, Cough and Sore Throat Remedies Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Cold, Cough and Sore Throat Remedies Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Cold, Cough and Sore Throat Remedies Market by Type
  1. 4.1 Cold, Cough and Sore Throat Remedies Type Introduction
  2. 4.1.1 Decongestants
  3. 4.1.2 Antibiotics
  4. 4.1.3 Antihistamines
  5. 4.1.4 Expectorants
  6. 4.1.5 Bronchodilators
  7. 4.1.6 Others
  8. 4.2 Global Cold, Cough and Sore Throat Remedies Sales Value by Type
  9. 4.2.1 Global Cold, Cough and Sore Throat Remedies Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Cold, Cough and Sore Throat Remedies Sales Value by Type (2021-2032)
  11. 4.2.3 Global Cold, Cough and Sore Throat Remedies Sales Value Share by Type (2021-2032)
5 Cold, Cough and Sore Throat Remedies Market by Application
  1. 5.1 Cold, Cough and Sore Throat Remedies Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Drug Stores
  5. 5.2 Global Cold, Cough and Sore Throat Remedies Sales Value by Application
  6. 5.2.1 Global Cold, Cough and Sore Throat Remedies Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cold, Cough and Sore Throat Remedies Sales Value by Application (2021-2032)
  8. 5.2.3 Global Cold, Cough and Sore Throat Remedies Sales Value Share by Application (2021-2032)
6 Cold, Cough and Sore Throat Remedies Regional Value Analysis
  1. 6.1 Global Cold, Cough and Sore Throat Remedies Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cold, Cough and Sore Throat Remedies Sales Value by Region (2021-2032)
  3. 6.2.1 Global Cold, Cough and Sore Throat Remedies Sales Value by Region: 2021-2026
  4. 6.2.2 Global Cold, Cough and Sore Throat Remedies Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cold, Cough and Sore Throat Remedies Sales Value (2021-2032)
  7. 6.3.2 North America Cold, Cough and Sore Throat Remedies Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Cold, Cough and Sore Throat Remedies Sales Value (2021-2032)
  10. 6.4.2 Europe Cold, Cough and Sore Throat Remedies Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Cold, Cough and Sore Throat Remedies Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Cold, Cough and Sore Throat Remedies Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Cold, Cough and Sore Throat Remedies Sales Value (2021-2032)
  16. 6.6.2 South America Cold, Cough and Sore Throat Remedies Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Cold, Cough and Sore Throat Remedies Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Cold, Cough and Sore Throat Remedies Sales Value Share by Country, 2025 VS 2032
7 Cold, Cough and Sore Throat Remedies Country-level Value Analysis
  1. 7.1 Global Cold, Cough and Sore Throat Remedies Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Cold, Cough and Sore Throat Remedies Sales Value by Country (2021-2032)
  3. 7.2.1 Global Cold, Cough and Sore Throat Remedies Sales Value by Country (2021-2026)
  4. 7.2.2 Global Cold, Cough and Sore Throat Remedies Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Cold, Cough and Sore Throat Remedies Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Cold, Cough and Sore Throat Remedies Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Cold, Cough and Sore Throat Remedies Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Prestige Brands
  2. 8.1.1 Prestige Brands Company Information
  3. 8.1.2 Prestige Brands Business Overview
  4. 8.1.3 Prestige Brands Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Prestige Brands Cold, Cough and Sore Throat Remedies Product Portfolio
  6. 8.1.5 Prestige Brands Recent Developments
  7. 8.2 Reckitt Benckiser
  8. 8.2.1 Reckitt Benckiser Company Information
  9. 8.2.2 Reckitt Benckiser Business Overview
  10. 8.2.3 Reckitt Benckiser Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Reckitt Benckiser Cold, Cough and Sore Throat Remedies Product Portfolio
  12. 8.2.5 Reckitt Benckiser Recent Developments
  13. 8.3 Sun Pharmaceutical Industries
  14. 8.3.1 Sun Pharmaceutical Industries Company Information
  15. 8.3.2 Sun Pharmaceutical Industries Business Overview
  16. 8.3.3 Sun Pharmaceutical Industries Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharmaceutical Industries Cold, Cough and Sore Throat Remedies Product Portfolio
  18. 8.3.5 Sun Pharmaceutical Industries Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Cold, Cough and Sore Throat Remedies Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Bayer
  26. 8.5.1 Bayer Company Information
  27. 8.5.2 Bayer Business Overview
  28. 8.5.3 Bayer Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer Cold, Cough and Sore Throat Remedies Product Portfolio
  30. 8.5.5 Bayer Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Cold, Cough and Sore Throat Remedies Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Cold, Cough and Sore Throat Remedies Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Novartis
  44. 8.8.1 Novartis Company Information
  45. 8.8.2 Novartis Business Overview
  46. 8.8.3 Novartis Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novartis Cold, Cough and Sore Throat Remedies Product Portfolio
  48. 8.8.5 Novartis Recent Developments
  49. 8.9 Johnson & Johnson
  50. 8.9.1 Johnson & Johnson Company Information
  51. 8.9.2 Johnson & Johnson Business Overview
  52. 8.9.3 Johnson & Johnson Cold, Cough and Sore Throat Remedies Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Johnson & Johnson Cold, Cough and Sore Throat Remedies Product Portfolio
  54. 8.9.5 Johnson & Johnson Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst